Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Exploratory Trial to Estimate Proportion of Patients With Tumor Cell Contaminated Leukapheresis Products With and Without Bortezomib With In-vivo Purging - Multiple Myeloma (MM)
Phase 2
Completed
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2016-03-09
- Last Posted Date
- 2021-06-18
- Lead Sponsor
- Siddhartha Ganguly
- Target Recruit Count
- 101
- Registration Number
- NCT02703779
- Locations
- 🇺🇸
The University of Kansas Medical Center, Westwood, Kansas, United States
News
No news found